FDA — authorised 31 August 2022
- Application: BLA761261
- Marketing authorisation holder: GENZYME CORP
- Local brand name: XENPOZYME
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 XENPOZYME in United States
FDA authorised XENPOZYME on 31 August 2022
Marketing authorisation
XENPOZYME in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is XENPOZYME approved in United States?
Yes. FDA authorised it on 31 August 2022.
Who is the marketing authorisation holder for XENPOZYME in United States?
GENZYME CORP holds the US marketing authorisation.